|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
9,000,000 |
Market
Cap: |
1.53(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.15 - $0.939 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Histogen is a biotechnology company focusing on the development and commercialization of medicines to treat chronic diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cooperative Gilde Healthcare Ii U.a. |
10% Owner |
|
2013-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,675 |
1,305,405 |
|
- |
|
Cooperative Gilde Healthcare Ii U.a. |
10% Owner |
|
2013-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,258,730 |
1,258,730 |
|
- |
|
Cashion Charles |
SVP, Finance, CFO and Sec. |
|
2013-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
43,072 |
149,738 |
|
- |
|
Advent Venture Partners Llp |
10% Owner |
|
2013-07-30 |
4 |
B |
$11.00 |
$2,090,594 |
I/I |
190,054 |
2,166,836 |
1.5 |
- |
|
Advent Venture Partners Llp |
10% Owner |
|
2013-07-30 |
4 |
A |
$11.00 |
$211,453 |
I/I |
19,223 |
1,976,782 |
|
- |
|
Advent Venture Partners Llp |
10% Owner |
|
2013-07-30 |
4 |
S |
$11.00 |
$5,885 |
I/I |
(535) |
1,957,559 |
|
- |
|
Advent Venture Partners Llp |
10% Owner |
|
2013-07-30 |
4 |
OE |
$0.08 |
$5,775 |
I/I |
70,003 |
1,958,094 |
|
- |
|
Advent Venture Partners Llp |
10% Owner |
|
2013-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,888,091 |
1,888,091 |
|
- |
|
Scopa James Paul |
Director |
|
2013-07-30 |
4 |
B |
$11.00 |
$1,817,915 |
I/I |
165,265 |
1,192,080 |
2.1 |
- |
|
Scopa James Paul |
Director |
|
2013-07-30 |
4 |
A |
$11.00 |
$183,876 |
I/I |
16,716 |
1,026,815 |
|
- |
|
Scopa James Paul |
Director |
|
2013-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,010,099 |
1,010,099 |
|
- |
|
Vander Vort John |
10% Owner |
|
2013-07-30 |
4 |
B |
$11.00 |
$1,817,915 |
I/I |
165,265 |
1,192,080 |
1.5 |
- |
|
Vander Vort John |
10% Owner |
|
2013-07-30 |
4 |
A |
$11.00 |
$183,876 |
I/I |
16,716 |
1,026,815 |
|
- |
|
Vander Vort John |
10% Owner |
|
2013-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,010,099 |
1,010,099 |
|
- |
|
Mpm Asset Management Investors Bv5 Llc |
10% Owner |
|
2013-07-30 |
4 |
B |
$11.00 |
$1,817,915 |
I/I |
165,265 |
1,192,080 |
1.5 |
- |
|
Mpm Asset Management Investors Bv5 Llc |
10% Owner |
|
2013-07-30 |
4 |
A |
$11.00 |
$183,876 |
I/I |
16,716 |
1,026,815 |
|
- |
|
Mpm Asset Management Investors Bv5 Llc |
10% Owner |
|
2013-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,010,099 |
1,010,099 |
|
- |
|
Aberdare Partners Iii Lp |
10% Owner |
|
2013-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
60,605 |
|
- |
|
Spada Alfred P. |
SVP, R&D and CSOOfficer |
|
2013-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
190,909 |
|
- |
|
Hale David F |
Director |
|
2013-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
121,211 |
|
- |
|
Burgess Gary C. |
Sr. VP, Clin. Res. & CMOOffice |
|
2013-07-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
121,212 |
|
- |
|
Mento Steven J |
President, CEO & DirectorOffic |
|
2013-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
275,151 |
|
- |
|
Cashion Charles |
SVP, Finance, CFO and Sec.Offi |
|
2013-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
106,666 |
|
- |
|
Klingenstein Paul H |
Director |
|
2013-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
60,605 |
|
- |
|
99 Records found
|
|
Page 4 of 4 |
|
|